Pidilite Industries Appoints Amit Agarwal as CFO Designate from October 9, 2026

Pidilite Industries has appointed Amit Agarwal as CFO Designate, with the appointment taking effect on October 9, 2026.  

The board approved the decision through a circular resolution on Friday, following a recommendation from the Nomination and Remuneration Committee.  

Previous Roles at Pfizer, HUL and Vedanta 

Agarwal has over 22 years of experience in finance, including accounting, reporting, audit and control. He has worked at Pfizer Limited, Hindustan Unilever Limited, and Vedanta Resources Limited. 

Pidilite's filing does not specify the roles Agarwal held at these companies or when he worked there. It also does not detail his responsibilities in his new position at Pidilite. 

Professional Qualifications 

Agarwal is a Chartered Accountant, Cost Accountant and Company Secretary, according to the company's disclosure dated October 9. 

His appointment is currently as CFO Designate. The filing does not state when he will take over as Chief Financial Officer or whether a separate appointment to that position has been approved. 

Board Decision 

The appointment was approved by Pidilite's board on October 9, 2026, after the Nomination and Remuneration Committee recommended the move. The company informed the stock exchanges of the decision on the same day. 

The disclosure was signed by Manisha Shetty, Company Secretary of Pidilite Industries Limited. 

Read More: Brigade Enterprises Share Price in Focus; To Invest ₹40,000 Crore Over Next 3 Years! 

Pidilite Industries Share Price Performance  

As of October 9, 2026, 2:03 pm, Pidilite Industries share price was trading at ₹1,479.70, up 1.34% from the previous closing price. 

Conclusion 

Amit Agarwal joins Pidilite's senior management as CFO Designate from October 9, 2026. He has more than 22 years of finance experience and has previously worked at Pfizer, Hindustan Unilever and Vedanta Resources. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.